14 - 15 May 2009
London
Book online here, alternatively call our credit card hotline 020 7501 6762.
To request an invoice, download and complete the pdf booking form stating your invoicing address and return via fax or post.
Cheque payments should be made payable to MA Healthcare Ltd and posted with a completed booking form.
| 08.30-09.25 | Registration and refreshments |
| 09.25-09.30 | Welcome & introduction |
| 09.30-10.00 | Risk factors and predisposition Professor Eamonn Maher Professor of Medical Genetics and Honorary Consultant of Clinical Genetics University of Birmingham School of Medicine |
| 10.00-10.30 | Paediatric kidney cancers Dr Gill Levitt Consultant in Oncology and Late Effects Great Ormond Street Hospital for Sick Children, London |
| 10.30-11.00 | Effective multidisciplinary approaches to management of renal cancer patients Dr Vincent Khoo Consultant and Honorary Senior Lecturer in Clinical Oncology Royal Marsden NHS Foundation Trust, London |
| 11.00–11.10 | Discussion |
| 11.10-11.30 | Refreshments and exhibition viewing |
| 11.30-12.00 | Advances in diagnostic imaging and staging of renal tumours Dr Giles Rottenberg Consultant Urologist Guys and St Thomas’ NHS Foundation Trust, London |
| 12.00-12.30 | Prognostic and predictive biomarkers – implications for treatment Professor Roz Banks Professor of Biomedical Proteomics St James’ University Hospital, Leeds |
| 12.30-12.40 | Discussion |
| 12.40-13.20 | Lunch and exhibition viewing |
| 13.20-13.40 | Tumour ablation for early renal cancer Dr Alice Gillams Senior Lecturer and Consultant University College London and University College London Hospital |
| 13.40-14.00 | Cryotherapy and partial nephrectomy for early stage disease Mr Chris Anderson Consultant Urological Surgeon St George's Hospital, London |
| 14.00-14.30 | Approaches for managing advanced and metastatic disease Dr James Larkin Consultant Medical Oncologist Royal Marsden Hospital NHS Foundation Trust, London |
| 14.30-15.00 | Laparoscopic vs open surgery Mr David Hrouda Consultant Urological Surgeon Imperial College Healthcare NHS Trust, London |
| 15.00-15.10 | Discussion |
| 15.10-15.30 | Refreshments and exhibition viewing |
| 15.30-16.00 | Advances in robotic surgery Mr Prokar Dasgupta Consultant Urological Surgeon Guy’s and St Thomas’ NHS Foundation Trust and King’s College Hospital, London |
| 16.00-16.30 | Role of intraoperative pathological consultations Dr Cathy Corbishley Consultant Histopathologist St George’s Healthcare NHS Trust, London |
| 16.30-17.00 | Adjuvant or neoadjuvant therapy? Dr Simon Chowdhury Consultant Medical Oncologist Guy’s and St Thomas’ NHS Foundation Trust and King’s College Hospital, London |
| 17.00 | Discussion and close of day one |
| 08.30-09.00 | Registration and refreshments |
| 09.00-09.30 | Role of tyrosine kinase and mTOR inhibitors in current and future therapies Dr Sara Ramsey Specialist Registrar in Urology Southern General Hospital, Glasgow |
| 09.30-10.00 | Efficacy of VEGF inhibition Professor JK Mellon Professor of Urology University of Leicester |
| 10.00-10.30 | Combination targeted therapies Dr Simon Chowdhury Consultant Medical Oncologist Guy’s and St Thomas’ NHS Foundation Trust and King’s College Hospital, London |
| 10.30-10.40 | Discussion |
| 10.40-11.10 | Refreshments and exhibition viewing |
| 11.10-11.40 | Are autologous vaccines the future of renal cancer therapy? Professor Angus Dalgleish Professor of Oncology St George’s University of London |
| 11.40-12.20 | Reaction to the NICE Guidelines: clinical vs cost-effectiveness Professor Jonathan Waxman Professor of Oncology Imperial College, London |
| 12.20-12.30 | Discussion |
| 12.30-13.20 | Lunch and exhibition viewing |
| Chair: | Professor John Wagstaff Professor of Medical Oncology, Swansea School of Medicine & Director of the Wales Cancer Trials Network |
| 13.20-13.50 | Launch of the UK Guidelines for the systemic treatment of renal cell carcinoma Dr Paul Nathan Consultant Medical Oncologist Mount Vernon Cancer Centre, Middlesex |
| 13.50-14.20 | Measuring the responses to therapy Professor John Wagstaff Professor of Medical Oncology, Swansea School of Medicine & Director of the Wales Cancer Trials Network |
| 14.20-14.50 | Long-term effects and toxicity of treatments for kidney cancer Dr Paul Nathan Consultant Medical Oncologist Mount Vernon Cancer Centre, Middlesex |
| 14.50-15.00 | Discussion |
| 15.00-15.20 | Refreshments and exhibition viewing |
| 15.20-15.50 | Helping patients cope with kidney cancer Wendy Ansell Macmillan Urology Nurse Specialist St Bartholomew’s Hospital, London |
| 15.50-16.45 | Case studies of effective care pathways Mr Chris Anderson Consultant Urological Surgeon St George’s Hospital, London & Dr Jonathan Shamash Consultant Medical Oncologist/Honorary Senior Lecturer, St Bart's and the London NHS Trust |
| 16.45-17.00 | Discussion |
| 17.00 | Close of conference |